Compare POET & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POET | IRMD |
|---|---|---|
| Founded | 1972 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2008 | 2014 |
| Metric | POET | IRMD |
|---|---|---|
| Price | $8.08 | $86.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $116.00 |
| AVG Volume (30 Days) | ★ 28.5M | 79.3K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $848.96 | $12.38 |
| Revenue Next Year | $700.00 | $11.31 |
| P/E Ratio | ★ N/A | $50.62 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $3.79 | $50.36 |
| 52 Week High | $15.50 | $107.90 |
| Indicator | POET | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 29.45 |
| Support Level | $5.40 | $82.64 |
| Resistance Level | $9.14 | $87.54 |
| Average True Range (ATR) | 1.37 | 3.08 |
| MACD | 0.20 | -0.49 |
| Stochastic Oscillator | 22.69 | 6.45 |
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.